Zevra Therapeutics Inc (ZVRA:NASDAQ)

$9.09 0.16 (1.79%)

watchlist-icon
search-icon
Profile Icon

This Week's Average Sentiment Analysis Score (0 to 100): 86

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]

Change Analysis Timeline Daily Weekly Monthly subspinner

Analysed Zevra Therapeutics Inc (ZVRA:NASDAQ) News Sources

Zevra Therapeutics to Present at the Citizens Life Sciences Conference

Yahoo Finance

Transpire Bio Strengthens its Leadership Team with Appointment of LaDuane Clifton as Chief Financial Officer

Yahoo Finance UK

Analysts Are Bullish on Top Healthcare Stocks: CervoMed (CRVO), Kodiak Sciences (KOD)

The Globe and Mail

ZVRA stock
ZVRA stock price
ZVRA stock price today
ZVRA stock prediction
ZVRA earnings date
ZVRA news
ZVRA price
ZVRA share
ZVRA share price
ZVRA shares
ZVRA ceo
ZVRA premarket
$ZVRA
ZVRA ticker
ZVRA after hours
ZVRA stock
ZVRA stock price
ZVRA stock price today
ZVRA stock prediction
ZVRA earnings date
ZVRA news
ZVRA price
ZVRA share
ZVRA share price
ZVRA shares
ZVRA ceo
ZVRA premarket
$ZVRA
ZVRA ticker
ZVRA after hours

Zevra Therapeutics Inc (ZVRA:NASDAQ) FAQs

toggle

What is the current price of Zevra Therapeutics Inc (ZVRA:NASDAQ)?

The current price of Zevra Therapeutics Inc (ZVRA:NASDAQ) is $9.09.


toggle

Zevra Therapeutics Inc (ZVRA:NASDAQ) absolute price change since previous trading day?

The absolute price change of Zevra Therapeutics Inc (ZVRA:NASDAQ) since the previous trading day is $0.16.


toggle

Zevra Therapeutics Inc (ZVRA:NASDAQ) percentage price change since previous trading day?

The percentage price change of Zevra Therapeutics Inc (ZVRA:NASDAQ) since the previous trading day is 1.79%.


toggle

What is This Week's average sentiment score for Zevra Therapeutics Inc (ZVRA:NASDAQ)?

This Week's average sentiment score for Zevra Therapeutics Inc (ZVRA:NASDAQ) is 86 out of 100.


toggle

What is This Week's average sentiment for Zevra Therapeutics Inc (ZVRA:NASDAQ)?

This Week's sentiment for Zevra Therapeutics Inc (ZVRA:NASDAQ) is .


Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.